PAMAM G4 Dendrimers & Vitamin D Nano Complex for delivery of Doxorubicin

Registration ID: IJNRD_215840

Published ID: IJNRD2403315

DOI: http://doi.one/10.1729/Journal.38481

Pragati Singh , Nancy Tiwari , Ranveer Singh , Priyanka Singh

Dendrimer, Doxorubicin, Vitamin D, Cancer therapy, Drug release kinetics, Targeted delivery, In vivo efficacy.

In cancer treatment, efficient drug delivery systems are imperative to enhance therapeutic efficacy while minimizing systemic toxicity. This study explores the potential of a novel nano-complex composed of PAMAM G4 dendrimers and vitamin D for the targeted delivery of doxorubicin (DOX), a widely used chemotherapeutic agent. The synthesis and characterization of the nano-complex were meticulously conducted, elucidating its physicochemical properties and structural integrity.The encapsulation of DOX within the nano-complex was optimized, ensuring high drug loading efficiency and sustained release kinetics. Moreover, the synergistic effects of vitamin D were harnessed to augment the anticancer activity of DOX while mitigating its adverse effects on normal tissues. Cellular uptake studies revealed enhanced internalization of the nano-complex in cancer cells, facilitated by receptor-mediated endocytosis mechanisms.In vitro studies demonstrated the superior cytotoxicity of the DOX-loaded nano-complex compared to free DOX, attributed to its targeted delivery and intracellular release. Furthermore, the nano-complex exhibited favorable biocompatibility profiles, minimizing off-target effects on healthy cells. In vivo efficacy assessments using xenograft tumor models corroborated the enhanced therapeutic outcomes of the nano-complex, showcasing significant tumor growth inhibition and prolonged survival rates compared to conventional DOX formulations. Pharmacokinetic studies indicated improved circulation half-life and bioavailability of DOX when delivered via the nano-complex.

Published Paper   E-Certificate

Pragati Singh, Nancy Tiwari, Ranveer Singh, & Priyanka Singh (March-2024). PAMAM G4 Dendrimers & Vitamin D Nano Complex for delivery of Doxorubicin. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(3), d102-d113. http://doi.one/10.1729/Journal.38481

Volume 9 Issue 3, March-2024

Pages : d102-d113

Paper Reg. ID: IJNRD_215840

Published Paper Id: IJNRD2403315

Downloads: 000121986

Research Area: Pharmacy

Country: Lucknow, Uttar Pradesh, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2403315.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2403315

Crossref DOI: http://doi.one/10.1729/Journal.38481

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details